EMG
IMCR icon

ETF Managers Group’s Immunocore IMCR Stock Holding History

ETF Managers Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$733K Buy
+14,822
New +$833K 0.02% 307
2022
Q4 		– Sell
-12,944
Closed -$608K – 602
2022
Q3 		$608K Sell
12,944
-914
-7% -$43.6K 0.02% 327
2022
Q2 		$498K Buy
13,858
+324
+2% +$10.5K 0.01% 486
2022
Q1 		$402K Buy
13,534
+49
+0.4% +$1.24K 0.01% 505
2021
Q4 		$460K Sell
13,485
-2,807
-17% -$102K 0.01% 527
2021
Q3 		$603K Buy
16,292
+3,130
+24% +$106K 0.01% 483
2021
Q2 		$464K Sell
13,162
-49
-0.4% -$1.89K 0.01% 548
2021
Q1 		$571K Buy
+13,211
New +$588K 0.01% 390

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return